Corvus Pharmaceuticals EPS Basic from Accounting Change (Quarterly) Analysis

Corvus Pharmaceuticals, Inc. (CRVS)

16.60 -0.93 (-5.31%) USD | NASDAQ | Feb 20, 16:00

16.53 -0.07 (-0.42%) After-Hours: 20:00

View EPS Basic from Accounting Change (Quarterly) for CRVS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Accounting Change (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	--
Plus Therapeutics, Inc.	--
Geron Corp.	--
Jaguar Health, Inc.	--
Krystal Biotech, Inc.	--